Baxter International (BAX) Operating Expenses (2009 - 2026)

Baxter International (BAX) has 18 years of Operating Expenses data on file, last reported at $867.0 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 2.85% year-over-year to $867.0 million in Q1 2026; TTM through Mar 2026 was $867.0 million, a 2.85% increase from a year earlier, with the FY2025 full-year figure at $3.4 billion, down 4.19% from the prior year.
• Operating Expenses for Q1 2026 stood at $867.0 million, up from $843.0 million in the prior quarter.
• Over the last five years, Operating Expenses for BAX reached as high as $1.2 billion in Q1 2024 and fell as low as $15.0 million in Q4 2023.
• Historically, Operating Expenses has averaged $903.4 million across 5 years, with a median of $1.1 billion in 2022.
• Across the five-year window, Operating Expenses soared 59.21% in 2022 and slumped 89.36% in 2023, its largest moves.
• Year by year, Operating Expenses stood at $141.0 million in 2022, then slumped by 89.36% to $15.0 million in 2023, then jumped by 7920.0% to $1.2 billion in 2024, then decreased by 29.93% to $843.0 million in 2025, then climbed by 2.85% to $867.0 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $867.0 million in Q1 2026, $843.0 million in Q1 2025, and $1.2 billion in Q1 2024.